321435-43-2

Basic information

• Product Name: (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid (3-methyl-pyridin-2-ylmethyl)-amide
• CAS NO: 321435-43-2
• Molecular Weight: 467.589
• Mol File: 321435-43-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid (3-methyl-pyridin-2-ylmethyl)-amide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid (3-methyl-pyridin-2-ylmethyl)-amide(321435-43-2)
• EPA Substance Registry System: (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid (3-methyl-pyridin-2-ylmethyl)-amide(321435-43-2)

Safety Data

• Hazardous Substances Data: 321435-43-2(Hazardous Substances Data)

Upstream product

• 321435-38-5 (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid allyl ester 
• 588729-32-2 (2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carboxylic acid 
• 588729-47-9 (R)-5,5-Dimethyl-thiazolidine-4-carboxylic acid allyl ester 
• 72778-00-8 (R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 
• 117918-23-7 (R)-3-tert-butoxycarbonyl-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 
• 150407-67-3 dihydro-5(S)-(hydroxymethyl)-3(R)-(phenylmethyl)-3(2H)-furanone 
• 153936-26-6 C-(3-methyl-pyridin-2-yl)-methylamine 
• 321435-39-6 (R)-3-((2S,4R)-4-Benzyl-5-oxo-tetrahydro-furan-2-carbonyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid 
• 321435-37-4 5,5-dimethyl-thiazolidine-3,4-dicarboxylic acid 4-allyl ester 3-tert-butyl ester 

Downstream Products

• 321435-44-3 (2R,4S)-2-Benzyl-4-(tert-butyl-dimethyl-silanyloxy)-5-{(R)-5,5-dimethyl-4-[(3-methyl-pyridin-2-ylmethyl)-carbamoyl]-thiazolidin-3-yl}-5-oxo-pentanoic acid 

Relevant articles and documents

Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus

A series of highly potent HIV protease inhibitors have been designed and synthesized. These compounds are active against various clinical viral isolates as well as wild-type virus. The synthesis and biological activity of these HIV protease inhibitors are discussed.